Avenue Therapeutics Inc (ATXI) stock has fallen -46.73% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ATXI stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 0. ATXI's rank also includes a short-term technical score of 4. The fundamental score for ATXI is 96. In addition to the average rating from Wall Street analysts, ATXI stock has a mean target price of 9. This means analysts expect the stock to gain 199.00% over the next 12 months.
What's Happening with ATXI Stock Today
Avenue Therapeutics Inc (ATXI) stock has fallen -3.22% while the S&P 500 has fallen -2.68% as of 11:32 AM on Wednesday, Oct 28. ATXI has fallen -$0.10 from the previous closing price of $3.11 on volume of 134,807 shares. Over the past year the S&P 500 has risen 8.66% while ATXI has fallen -46.73%. ATXI lost -$0.66 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Avenue Therapeutics Inc (ATXI) Stock.
